Hugtenburg Jacqueline G, Timmers Lonneke, Elders Petra Jm, Vervloet Marcia, van Dijk Liset
EMGO+ Institute and Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam.
Patient Prefer Adherence. 2013 Jul 10;7:675-82. doi: 10.2147/PPA.S29549. Print 2013.
Nonadherence with medication is a complex and multidimensional health care problem. The causes may be related to the patient, treatment, and/or health care provider. As a consequence, substantial numbers of patients do not benefit optimally from pharmacotherapy, resulting in increased morbidity and mortality as well as increased societal costs. Several interventions may contribute to improved adherence. However, most interventions have only a modest effect. Thus, despite the many efforts made, there has been little progress made as yet in tackling the problem of nonadherence.
This paper summarizes the definitions and taxonomy of adherence with medication, as well as types and causes of nonadherence. In addition, interventions aimed at improvement of adherence are discussed.
There is not just one solution for the nonadherence problem that fits all patients. Most interventions to improve adherence are aimed at all patients regardless of whether they are adherent or not. Recently, a number of tailored interventions have been described in the literature. Modern techniques are useful. Electronic pill boxes combined with Short Message Service reminders are specifically designed to improve unintentional adherence and have resulted in an increase in refill adherence in diabetic patients with suboptimal adherence. Tailored Internet interventions are a possibility for influencing patient drug-taking behavior and show promising results. Tailored counseling interventions targeted at the underlying causes of nonadherence seem an attractive method for supporting patients with their use of drugs. However, despite the plausible theoretical framework, data on long-term health effects of the various interventions are not available. To improve adherence effectively, there is a need for a tailored approach based on the type and cause of nonadherence and the specific needs of the patient.
药物治疗依从性差是一个复杂且多维度的医疗保健问题。其原因可能与患者、治疗以及/或者医疗保健提供者有关。因此,大量患者无法从药物治疗中获得最佳益处,导致发病率和死亡率上升,以及社会成本增加。有几种干预措施可能有助于提高依从性。然而,大多数干预措施的效果都较为有限。因此,尽管已经做出了许多努力,但在解决依从性差的问题上,目前进展甚微。
本文总结了药物治疗依从性的定义和分类,以及不依从的类型和原因。此外,还讨论了旨在提高依从性的干预措施。
对于依从性差的问题,没有一种适用于所有患者的解决方案。大多数提高依从性的干预措施针对的是所有患者,而不论他们是否依从。最近,文献中描述了一些针对性的干预措施。现代技术很有用。电子药盒与短信提醒相结合,专门设计用于提高无意的依从性,并已使依从性欠佳的糖尿病患者的续方依从性有所提高。针对性的互联网干预措施有可能影响患者的用药行为,并显示出有希望的结果。针对不依从的根本原因进行的针对性咨询干预措施,似乎是支持患者用药的一种有吸引力的方法。然而,尽管有合理的理论框架,但尚无关于各种干预措施长期健康影响的数据。为了有效提高依从性,需要根据不依从的类型和原因以及患者的具体需求采取针对性的方法。